Siham Abdelgani

Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes ( <scp>EDICT</scp> )

Olga Lavynenko, Muhammad Abdul‐Ghani, Mariam Alatrach et al. · Diabetes Obesity and Metabolism · 2022 · 40 citations

Trimethoprim-sulfamethoxazole vs. colistin or ampicillin–sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii: A retrospective matched cohort study

Ayelet Raz‐Pasteur, Yael Liron, Reut Amir-Ronen et al. · Journal of Global Antimicrobial Resistance · 2018 · 28 citations

Antibiotic Resistance, Drug Resistance, Antimicrobial Therapy +16

Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients

Siham Abdelgani, Ahmed Khattab, John M. Adams et al. · Diabetes Care · 2023 · 25 citations · Full text

Empagliflozin Reduces Liver Fat in Individuals With and Without Diabetes

Siham Abdelgani, Ahmed Khattab, John M. Adams et al. · Diabetes Care · 2024 · 25 citations · Full text

Gastric and urinary bladder pressures correlate with intra-abdominal pressure in patients with morbid obesity

Shadi Hamoud, Siham Abdelgani, Michal Mekel et al. · Journal of Clinical Monitoring and Computing · 2021 · 11 citations · Full text